OGI News | Roxom Stocks

Invest Private Security Newsroom

Market Overview

Indices and commodities.

Bitcoin treasury preferreds.

The artificial intelligence theme.

Bitcoin Treasuries

Companies holding bitcoin.

Sectors, global markets and rates.

Popular Portfolios

13F filings, smart money.

Borrow USDT or USDC against your BTC without giving it up.

Switch your bitcoin-backed loan and pay less interest.

Borrow, invest, keep the spread.

Stock Dividends

Dividends from tokenized equities.

Company

Our leadership team, mission, and investors.

Vision, purpose, and architecture behind Roxom.

Terms, privacy, and disclosures.

Resources

Guides, FAQs & support.

Trading logic, platform rules, and fundamentals.

Connect, authenticate, and build with our API.

Current platform health and incidents.

Loading chart

Pay with

1 BTC

=

- USD

Loading market data...

Loading chart

Pay with

OG

Volume

246.01K

Loading chart

OG

OGIOrganigram Global Inc. Common Shares

OGI

Pay with—

Available Balance0.00

OG

Mkt Cap

$134.3M

Volume

246.01K

Next Earnings

N/A

Chart Financials Earnings News About Insider Filings

Organigram Bets Big On Europe With Sanity Group TakeoverOrganigram Global announced a proposed acquisition of Sanity Group, a German cannabis company, for €113.4 million upfront plus up to €113.8 million in earnout consideration. The deal aims to establish Organigram as a global cannabis pure-play with significant European market presence. Funding will come from cash on hand, a new credit facility, and a €47.8 million investment from British American Tobacco. OGI shares rose 7.09% in premarket trading, though technical indicators show bearish short-to-medium term trends.Benzinga · Feb 18, 2026

OrganiGram (OGI) Joins Cannabis Stock Rally After Trump Signals Policy ShiftOrganiGram's stock surged 15% after former President Trump's social media post suggesting potential health benefits of cannabis and a possible shift in federal drug policy, boosting optimism in the cannabis industry.Benzinga · Sep 29, 2025

DEA Accused Of Bias In Cannabis Rescheduling Hearings: Weed Stocks Plummeted In 2024 As Process Drags OnThe DEA is accused of bias in the cannabis rescheduling hearings, leading to a plunge in weed stocks in 2024 as the process drags on. A DEA judge has ordered the agency to respond to allegations of improper communications with opponents of cannabis reform.Benzinga · Jan 8, 2025

Organigram Wants To Become Canada's Largest Cannabis Company By Market Share Via $71M Acquisition DealOrganigram Holdings Inc. announced the acquisition of Motif Labs Ltd. for CA$90 million, solidifying its position as Canada's largest cannabis company by market share. The deal enhances Organigram's capabilities and expands its presence nationwide, positioning it for international growth.Benzinga · Dec 6, 2024

Are You Missing Out On This NASDAQ-Listed Weed Stock? Low-Cost Model Meets European DemandVillage Farms, a NASDAQ-listed cannabis company, is focused on growing its international business, particularly in Germany, Australia, and the UK. The company's sales margins are recovering, and it plans to prioritize its branded domestic cannabis business and international sales.Benzinga · Dec 5, 2024

Decibel Cannabis: One Acquisition Could Be The Key To Unlocking $20M In Cash FlowDecibel Cannabis is poised for significant growth, with a projected free cash flow of $20 million for 2025 and a 54% FCF yield. The acquisition of AgMedica is expected to enhance Decibel's market position and growth prospects by expanding its product portfolio and distribution network.Benzinga · Dec 4, 2024

Tobacco Giant Invests $30.8M In Cannabis Company: BAT Private Placement Second Of Three TranchesOrganigram Holdings Inc. (OGI) has closed the second tranche of a $92.3 million strategic investment from British American Tobacco plc (BTI) subsidiary BT DE Investments Inc. The investment will fund Organigram's international expansion plans, including investments in the U.S. and German markets.Benzinga · Sep 3, 2024

A $2 Billion Opportunity In Cannabis: How A Tobacco Giant Is Helping Organigram Seize The German Market - BenzingaOrganigram Holdings, a Canadian cannabis company, is partnering with Sanity Group, a German cannabis company, to expand its presence in the German market. The partnership is supported by British American Tobacco, a strategic investor in both companies. The article discusses the market potential, growth, and capabilities of the two companies in the German cannabis market.Benzinga · Jul 11, 2024

Aurora Cannabis Shoots For $512M Market: Marijuana Stock Analyst Initiates Coverage With NeutralAurora Cannabis (NASDAQ: ACB), a key player in the global medical marijuana market, stands at a strategic crossroads. Pablo Zuanic, a seasoned marijuana stock analyst from Zuanic & Associates, has initiated coverage on stock with a neutral rating. The core of his analysis hinges on whether Aurora's push into international markets will bolster its future or accelerate its challenges. Zuanic's report delivers actionable insights into Aurora's finances and strategy, equipping investors to interpret earnings, assess global market impacts and make informed decisions in a dynamic industry. "ACB is among the two largest medical cannabis companies globally and stands to benefit significantly from nascent international markets, which we estimate could see a tenfold increase over the next decade," Zuanic wrote. Financial Overview Zuanic's report charts Aurora’s financial forecasts against its ambitious global expansion plans. Despite projecting a potential tenfold increase in international market size over the next decade, the analyst remains cautious. He points out the company's need to prove its growth strategies amid an increasingly competitive and uncertain global landscape. Aurora Cannabis reported FY24 sales at $270.3 million, with projections increasing to $355.3 million by FY27. According to Zuanic, Aurora's financial projections show significant improvements across key metrics over the next few years. The EPS (earnings per share) is forecasted to rise from -$0.12 in FY25 to $0.39 in FY27, indicating a turnaround from a loss per share to a profit per share, which suggests improving ...Full story available on Benzinga.comBenzinga · Jun 28, 2024

Canadian Vs. U.S. Cannabis Companies: Who Is Winning The Market Race To Weed Profits?The financial landscapes of Canadian and U.S. cannabis operators showcase distinct paths in the quest for profitability, driven by varying market dynamics and regulatory environments. According to recent financial data from Beacon Securities, the analysis of key financial metrics such as EV/EBITDA and P/CFO ratios reveals crucial insights. U.S. cannabis operators demonstrate a more robust market performance with an average EV/EBITDA ratio of 8.0x, compared to their Canadian counterparts who post a significantly higher average of 20.6x. This disparity indicates that American companies like Curaleaf Holdings, Inc. (OTC: CURA) and Green Thumb Industries Inc. (OTC: GTBIF) are generally priced more attractively relative to their earnings before interest, taxes, depreciation and amortization—a key profitability metric. Moreover, the Price to Cash Flow from Operations (P/CFO), which assesses the value of a company's stock price relative to its operating cash ...Full story available on Benzinga.comBenzinga · Jun 25, 2024

to start trading

OG

OGIOrganigram Global Inc. Common Shares

OGI

Pay with—

Available Balance0.00

Your PositionYou don't own any OGI yet.

Related Tickers

Earnings